Orphazymes kursridt, Sanofi opgiver diabetesmarkedet og Leo Pharma rammer plet med fremtidshåb

from MedWatch · host Watch Medier

MedWatch-redaktionen taler om biotekselskabet Orphazyme, Sanofis exit fra diabetesmarkedet og Leo Pharmas nye studieresultater, der giver håb om at kunne konkurrere med blockbustermidlet Dupixent.

Episode metadata supplied by the publisher feed · Published Dec 13, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

Orphazymes kursridt, Sanofi opgiver diabetesmarkedet og Leo Pharma rammer plet med fremtidshåb

0:00 11:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MedWatch?

This episode is 11 minutes long.

When was this MedWatch episode published?

This episode was published on December 13, 2019.

Can I download this MedWatch episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!